Breaking Industry News
RxLink Profile
RxLink, LLC - Strategic Pharmacy Business Services - RxLink - 2000 All Rights Reserved
11/02/2010 Strattera - A federal appeals court has extended a temporary order blocking 10 companies from selling generic versions of Eli Lilly and Co's Strattera attention deficit disorder drug.The extension was granted thursday by the U.S. Federal Circuit Court of Appeals in Washington, D.C. It continues until that court can consider papers filedas Lilly appeals a lower court ruling declaringits patent invalid, court records show. Such an extension could last several weeks.
11/02/2010 Breckenridge is experiencing a disruption in supply on Hyoscyamine 0.125mg, they expect an 8 week delay...
11/03/2010 Fexofenadine - Pending change in monograph from Rx to OTC, Prasco will no longer market Fexofenadine Hydrochloride tablets after current supplies have been depleted.
11/03/2010 Novartis Pharmaceuticals Corporation in agreement with the Food and Drug Administration, is sending healthcare professionals a communication regarding medication errors associated with the use of EXELON Patch (rivastigmine transdermal system).
